EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C11H9N3O2 |
| Net Charge | 0 |
| Average Mass | 215.212 |
| Monoisotopic Mass | 215.06948 |
| SMILES | O/N=C/c1cc(O)cc(-c2ccccn2)n1 |
| InChI | InChI=1S/C11H9N3O2/c15-9-5-8(7-13-16)14-11(6-9)10-3-1-2-4-12-10/h1-7,16H,(H,14,15)/b13-7+ |
| InChIKey | XLFYSDMKBLTHTJ-NTUHNPAUSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Actinoalloteichus cyanogriseus (ncbitaxon:65497) | - | PubMed (21770434) | Ethyl acetate extract of fermentation broth Strain: WH1 2216-6 |
| Roles Classification |
|---|
| Biological Roles: | marine metabolite Any metabolite produced during a metabolic reaction in marine macro- and microorganisms. bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| caerulomycin H (CHEBI:69227) has parent hydride 2,2'-bipyridine (CHEBI:30351) |
| caerulomycin H (CHEBI:69227) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin H (CHEBI:69227) has role bacterial metabolite (CHEBI:76969) |
| caerulomycin H (CHEBI:69227) has role marine metabolite (CHEBI:76507) |
| caerulomycin H (CHEBI:69227) is a aldoxime (CHEBI:22307) |
| caerulomycin H (CHEBI:69227) is a bipyridines (CHEBI:50511) |
| caerulomycin H (CHEBI:69227) is a monohydroxypyridine (CHEBI:38182) |
| caerulomycin H (CHEBI:69227) is a pyridine alkaloid (CHEBI:26416) |
| IUPAC Name |
|---|
| 6-[(E)-(hydroxyimino)methyl]-2,2'-bipyridin-4-ol |
| Synonym | Source |
|---|---|
| (E)-4-hydroxy-2,2'-bipyridine-6-carbaldehyde oxime | ChEBI |
| Registry Numbers | Sources |
|---|---|
| Reaxys:21856153 | Reaxys |
| Citations |
|---|